Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04000750 · ClinicalTrials.gov registry record · NA

Time-Restricted Eating and Muscle Hypertrophy

A NA study of Muscle Hypertrophy and Healthy and Well-Trained Men and Women, sponsored by California State University, Fullerton.

Completed
Registry status
NA
Development phase
20
Enrollment target
1
Study location

NCT04000750 is a NA study of Muscle Hypertrophy and Healthy and Well-Trained Men and Women that has completed, run by California State University, Fullerton. The registered enrollment target is 20 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04000750, a NA study of Muscle Hypertrophy and Healthy and Well-Trained Men and Women, has completed, sponsored by California State University, Fullerton.

COMPLETED
Registry status
NA
Development phase
20 participants
Enrollment target
1
Study location

Study Summary

The purpose is to examine the effects of time-restricted eating (TRE; consuming all calories within an 8-hour period each day) vs. normal eating (CON; consuming same kcals and protein as TRE, but during a 10-13 hr eating window each day) during 8 weeks of resistance exercise on body composition and muscle mass (whole muscle and single fiber), muscular performance, anabolic protein signaling, single muscle fiber characteristics, and the gut microbiome in well-trained young men and women.

Interventions

  • OTHER Resistance Training
  • DIETARY_SUPPLEMENT Whey Protein
  • OTHER Time Restricted Eating
  • OTHER Normal Feeding

Study Locations (1)

California

  • Center for Sport Performance at California State University, Fullerton - Fullerton

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2019-06-24
Est. Completion 2023-02-05
Phase NA

What the Registry Record Tells You About NCT04000750

The ClinicalTrials.gov registry entry for NCT04000750 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is California State University, Fullerton, which has 3 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Muscle Hypertrophy appearing as the primary indexed condition, and to 4 interventions - of which Resistance Training is the first listed.

NCT04000750 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT04000750 about?

NCT04000750 is a clinical study titled "Time-Restricted Eating and Muscle Hypertrophy". The purpose is to examine the effects of time-restricted eating (TRE; consuming all calories within an 8-hour period each day) vs. normal eating (CON; consuming same kcals and protein as TRE, but during a 10-13 hr eating window each day) during 8 weeks of resistance exercise on body composition and ...

What is the current status of trial NCT04000750?

This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2019-06-24. Estimated completion is 2023-02-05.

What conditions does trial NCT04000750 study?

This clinical trial studies the following conditions: Muscle Hypertrophy, Healthy and Well-Trained Men and Women.

What interventions are being tested in trial NCT04000750?

The interventions under investigation include: Resistance Training (OTHER), Whey Protein (DIETARY_SUPPLEMENT), Time Restricted Eating (OTHER), Normal Feeding (OTHER).

Who is sponsoring clinical trial NCT04000750?

This trial is sponsored by California State University, Fullerton, which has 3 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04000750 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.